Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul A. Wender

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
Natural Product Reports|March 5, 2014
Toward the ideal synthesis and molecular function through synthesis-informed designPaul A Wender
Tetrahedron|January 17, 2012
Function Oriented Synthesis: Preparation and Initial Biological Evaluation of New A-Ring-Modified BryologsPaul A Wender, Jenny Reuber
Journal of the American Chemical Society|June 4, 2009
Cyclocarboamination of alkynes with aziridines: synthesis of 2,3-dihydropyrroles by a catalyzed formal [3 + 2] cycloadditionPaul A Wender, Daniel Strand
Bioorganic & Medicinal Chemistry Letters|May 6, 2003
Photoinduced cleavage of DNA by bromofluoroacetophenone-pyrrolecarboxamide conjugatesPaul A Wender, Raok Jeon
Organic Letters|September 20, 2014
Improved protein kinase C affinity through final step diversification of a simplified salicylate-derived bryostatin analog scaffoldPaul A Wender, Daryl Staveness
Journal of the American Chemical Society|May 31, 2011
Total synthesis of bryostatin 9Paul A Wender, Adam J Schrier
Organic Letters|July 1, 2008
The design, synthesis, and evaluation of C7 diversified bryostatin analogs reveals a hot spot for PKC affinityPaul A Wender, Vishal A Verma
Organic Letters|September 22, 2006
Synthesis and PKC binding of a new class of a-ring diversifiable bryostatin analogues utilizing a double asymmetric hydrogenation and cross-coupling strategyPaul A Wender, Joshua C Horan
Journal of the American Chemical Society|April 20, 2006
Rhodium(I)-catalyzed [4+2+2] cycloadditions of 1,3-dienes, alkenes, and alkynes for the synthesis of cyclooctadienesPaul A Wender, Justin P Christy
Synthesis|March 28, 2014
Lead Diversification through a Prins-Driven Macrocyclization Strategy: Application to C13-Diversified Bryostatin AnaloguesPaul A Wender, Kelvin L Billingsley
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
Natural Product Reports|March 5, 2014
Toward the ideal synthesis and molecular function through synthesis-informed designPaul A Wender
Tetrahedron|January 17, 2012
Function Oriented Synthesis: Preparation and Initial Biological Evaluation of New A-Ring-Modified BryologsPaul A Wender, Jenny Reuber
Journal of the American Chemical Society|June 4, 2009
Cyclocarboamination of alkynes with aziridines: synthesis of 2,3-dihydropyrroles by a catalyzed formal [3 + 2] cycloadditionPaul A Wender, Daniel Strand
Bioorganic & Medicinal Chemistry Letters|May 6, 2003
Photoinduced cleavage of DNA by bromofluoroacetophenone-pyrrolecarboxamide conjugatesPaul A Wender, Raok Jeon
Organic Letters|September 20, 2014
Improved protein kinase C affinity through final step diversification of a simplified salicylate-derived bryostatin analog scaffoldPaul A Wender, Daryl Staveness
Journal of the American Chemical Society|May 31, 2011
Total synthesis of bryostatin 9Paul A Wender, Adam J Schrier
Organic Letters|July 1, 2008
The design, synthesis, and evaluation of C7 diversified bryostatin analogs reveals a hot spot for PKC affinityPaul A Wender, Vishal A Verma
Organic Letters|September 22, 2006
Synthesis and PKC binding of a new class of a-ring diversifiable bryostatin analogues utilizing a double asymmetric hydrogenation and cross-coupling strategyPaul A Wender, Joshua C Horan
Journal of the American Chemical Society|April 20, 2006
Rhodium(I)-catalyzed [4+2+2] cycloadditions of 1,3-dienes, alkenes, and alkynes for the synthesis of cyclooctadienesPaul A Wender, Justin P Christy
Synthesis|March 28, 2014
Lead Diversification through a Prins-Driven Macrocyclization Strategy: Application to C13-Diversified Bryostatin AnaloguesPaul A Wender, Kelvin L Billingsley
Pageof 17